965 related articles for article (PubMed ID: 35913134)
1. Repressed Ang 1-7 in COVID-19 Is Inversely Associated with Inflammation and Coagulation.
Carpenter RM; Young MK; Petri WAO; Lyons GR; Gilchrist C; Carey RM; Petri WA
mSphere; 2022 Aug; 7(4):e0022022. PubMed ID: 35913134
[TBL] [Abstract][Full Text] [Related]
2. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
[TBL] [Abstract][Full Text] [Related]
3. Two hits to the renin-angiotensin system may play a key role in severe COVID-19.
Tseng YH; Yang RC; Lu TS
Kaohsiung J Med Sci; 2020 Jun; 36(6):389-392. PubMed ID: 32492292
[TBL] [Abstract][Full Text] [Related]
4. ACE2 and COVID-19 and the resulting ARDS.
Zhang X; Li S; Niu S
Postgrad Med J; 2020 Jul; 96(1137):403-407. PubMed ID: 32522846
[TBL] [Abstract][Full Text] [Related]
5. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
Hrenak J; Simko F
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II Exaggerates SARS-CoV-2 Specific T-Cell Response in Convalescent Individuals following COVID-19.
Almutlaq M; Mansour FA; Alghamdi J; Alhendi Y; Alamro AA; Alghamdi AA; Alamri HS; Alroqi F; Barhoumi T
Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955801
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Wang K; Gheblawi M; Nikhanj A; Munan M; MacIntyre E; O'Neil C; Poglitsch M; Colombo D; Del Nonno F; Kassiri Z; Sligl W; Oudit GY
Hypertension; 2022 Feb; 79(2):365-378. PubMed ID: 34844421
[TBL] [Abstract][Full Text] [Related]
8. Renin-Angiotensin System and Sex Differences in COVID-19: A Critical Assessment.
Chappell MC
Circ Res; 2023 May; 132(10):1320-1337. PubMed ID: 37167353
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin II receptors: Impact for COVID-19 severity.
Aksoy H; Karadag AS; Wollina U
Dermatol Ther; 2020 Nov; 33(6):e13989. PubMed ID: 32645228
[TBL] [Abstract][Full Text] [Related]
10. Insights on SARS-CoV-2 Molecular Interactions With the Renin-Angiotensin System.
Costa LB; Perez LG; Palmeira VA; Macedo E Cordeiro T; Ribeiro VT; Lanza K; Simões E Silva AC
Front Cell Dev Biol; 2020; 8():559841. PubMed ID: 33042994
[TBL] [Abstract][Full Text] [Related]
11. The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure.
Angeli F; Zappa M; Reboldi G; Gentile G; Trapasso M; Spanevello A; Verdecchia P
Eur J Intern Med; 2023 Mar; 109():12-21. PubMed ID: 36528504
[TBL] [Abstract][Full Text] [Related]
12. Hypothesis for renin-angiotensin inhibitor mitigation of COVID-19.
Sackin H
Med Hypotheses; 2021 Jul; 152():110609. PubMed ID: 34048987
[TBL] [Abstract][Full Text] [Related]
13. Correcting the imbalanced protective RAS in COVID-19 with angiotensin AT2-receptor agonists.
Steckelings UM; Sumners C
Clin Sci (Lond); 2020 Nov; 134(22):2987-3006. PubMed ID: 33210709
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 Infections and ACE2: Clinical Outcomes Linked With Increased Morbidity and Mortality in Individuals With Diabetes.
Obukhov AG; Stevens BR; Prasad R; Li Calzi S; Boulton ME; Raizada MK; Oudit GY; Grant MB
Diabetes; 2020 Sep; 69(9):1875-1886. PubMed ID: 32669391
[TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19, and the Renin-Angiotensin System: Pressing Needs and Best Research Practices.
Sparks MA; South AM; Badley AD; Baker-Smith CM; Batlle D; Bozkurt B; Cattaneo R; Crowley SD; Dell'Italia LJ; Ford AL; Griendling K; Gurley SB; Kasner SE; Murray JA; Nath KA; Pfeffer MA; Rangaswami J; Taylor WR; Garovic VD
Hypertension; 2020 Nov; 76(5):1350-1367. PubMed ID: 32981369
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin I and II Stimulate Cell Invasion of SARS-CoV-2: Potential Mechanism via Inhibition of ACE2 Arm of RAS.
Zorad S; Skrabanova M; Zilkova M; Cente M; Turic Csokova N; Kovacech B; Cizkova D; Filipcik P
Physiol Res; 2024 Mar; 73(1):27-35. PubMed ID: 38466002
[TBL] [Abstract][Full Text] [Related]
17. Spike-mediated ACE2 down-regulation was involved in the pathogenesis of SARS-CoV-2 infection.
Gao X; Zhang S; Gou J; Wen Y; Fan L; Zhou J; Zhou G; Xu G; Zhang Z
J Infect; 2022 Oct; 85(4):418-427. PubMed ID: 35793758
[TBL] [Abstract][Full Text] [Related]
18. Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.
Méndez-García LA; Escobedo G; Minguer-Uribe AG; Viurcos-Sanabria R; Aguayo-Guerrero JA; Carrillo-Ruiz JD; Solleiro-Villavicencio H
Front Cell Neurosci; 2022; 16():977039. PubMed ID: 36187294
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin II Type I Receptor (AT1R): The Gate towards COVID-19-Associated Diseases.
El-Arif G; Khazaal S; Farhat A; Harb J; Annweiler C; Wu Y; Cao Z; Kovacic H; Abi Khattar Z; Fajloun Z; Sabatier JM
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408447
[TBL] [Abstract][Full Text] [Related]
20. ACE2/Ang-(1-7)/Mas1 axis and the vascular system: vasoprotection to COVID-19-associated vascular disease.
Kuriakose J; Montezano AC; Touyz RM
Clin Sci (Lond); 2021 Jan; 135(2):387-407. PubMed ID: 33511992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
